第 1 到 21 筆結果,共 21 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2023 | Dose-tapering trajectories in patients with remitted psychosis undergoing guided antipsychotic reduction to reach minimum effective dose | CHEN-CHUNG LIU ; MING-HSIEN HSIEH ; YI-LING CHIEN ; CHIH-MIN LIU ; YI-TING LIN ; TZUNG-JENG HWANG ; HAI-GWO HWU | European psychiatry : the journal of the Association of European Psychiatrists | |||
2 | 2023 | Guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis: a 2-year randomized controlled trial with a naturalistic cohort | CHEN-CHUNG LIU ; MING-HSIEN HSIEH ; YI-LING CHIEN ; CHIH-MIN LIU ; YI-TING LIN ; TZUNG-JENG HWANG ; HAI-GWO HWU | Psychological medicine | |||
3 | 2022 | Hemispheric lateralization of semantic processing before and after aripiprazole treatment in first-episode psychosis or ultra-high risk state | TZUNG-JENG HWANG ; Chan, Chia-Ta; Hsieh, Cheng-Yu; CHIH-MIN LIU ; CHEN-CHUNG LIU ; YI-LING CHIEN ; MING-HSIEN HSIEH ; YI-TING LIN ; Chou, Tai-Li | Schizophrenia (Heidelberg, Germany) | 0 | 0 | |
4 | 2022 | Discontinuing Antipsychotic Medication After Remission from First-Episode Psychosis: A Survey of Psychiatrists’ Attitudes in Taiwan | Yen K.; CHEN-CHUNG LIU ; YI-TING LIN ; YI-LING CHIEN ; MING-HSIEN HSIEH ; CHIH-MIN LIU ; TZUNG-JENG HWANG ; Liao, Wei-Hsiang; HAI-GWO HWU | Neuropsychiatric Disease and Treatment | 2 | 2 | |
5 | 2022 | The plasma level of complement component 4A decreases with aripiprazole treatment in patients with early psychosis | CHIH-MIN LIU ; CHEN-CHUNG LIU ; MING-HSIEN HSIEH ; TZUNG-JENG HWANG ; YI-TING LIN ; YI-LING CHIEN ; HAI-GWO HWU | Psychiatry Research | 2 | 2 | |
6 | 2022 | Detection of advanced brain aging in schizophrenia and its structural underpinning by using normative brain age metrics | Chen C.-L.; TZUNG-JENG HWANG ; Tung Y.-H.; Yang L.-Y.; Hsu Y.-C.; CHIH-MIN LIU ; YI-TING LIN ; MING-HSIEN HSIEH ; CHEN-CHUNG LIU ; YI-LING CHIEN ; HAI-GWO HWU ; Tseng W.-Y.I. | NeuroImage: Clinical | 7 | 4 | |
7 | 2022 | Follow-up of subjects labelled with putative pre-psychotic states: Viewed from a transdiagnostic clinical high-at-risk mental state (CHARMS) paradigm | CHEN-CHUNG LIU ; CHIH-MIN LIU ; YI-LING CHIEN ; YI-TING LIN ; MING-HSIEN HSIEH ; TZUNG-JENG HWANG ; HAI-GWO HWU | Journal of the Formosan Medical Association | 3 | 2 | |
8 | 2022 | A quarter of century after: The changing ecology of psychiatric emergency services | Chen, Wen-Hao; MING-HSIEN HSIEH ; SHIH-CHENG LIAO ; CHEN-CHUNG LIU ; CHIH-MIN LIU ; CHI-SHIN WU ; YI-TING LIN ; TZUNG-JENG HWANG ; YI-LING CHIEN | Asia-Pacific Psychiatry | 1 | 2 | |
9 | 2022 | Protocol of guided antipsychotic reduction to reach minimum effective dose (GARMED) in patients with remitted psychosis based on pragmatic design | CHEN-CHUNG LIU ; MING-HSIEN HSIEH ; YI-LING CHIEN ; CHIH-MIN LIU ; YI-TING LIN ; TZUNG-JENG HWANG ; HAI-GWO HWU | Early Intervention in Psychiatry | 5 | 5 | |
10 | 2021 | Challenging the Minimum Effective Antipsychotic Dose During Maintenance: Implications From 10-Year Follow-Up of First Episode Psychosis | CHEN-CHUNG LIU ; CHIH-MIN LIU ; YI-LING CHIEN ; YI-TING LIN ; MING-HSIEN HSIEH ; TZUNG-JENG HWANG ; HAI-GWO HWU | Frontiers in Psychiatry | 5 | 4 | |
11 | 2020 | Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms? | Jen Y.-W.; TZUNG-JENG HWANG ; Chan H.-Y.; MING-HSIEN HSIEH ; CHEN-CHUNG LIU ; CHIH-MIN LIU ; HAI-GWO HWU ; CHING-HUA KUO ; YI-TING LIN ; YI-LING CHIEN ; WEI J. CHEN | BMC Psychiatry | 7 | 7 | |
12 | 2020 | Stigmas toward psychosis-related clinical features among the general public in Taiwan | Wang Y.-C.; YI-TING LIN ; CHIH-MIN LIU ; TZUNG-JENG HWANG ; MING-HSIEN HSIEH ; YI-LING CHIEN ; HAI-GWO HWU ; CHEN-CHUNG LIU | Asia-Pacific Psychiatry | 9 | 9 | |
13 | 2019 | Auditory event-related potentials in antipsychotic-free subjects with ultra-high-risk state and first-episode psychosis | MING-HSIEN HSIEH ; YI-TING LIN ; YI-LING CHIEN ; TZUNG-JENG HWANG ; HAI-GWO HWU ; CHIH-MIN LIU ; CHEN-CHUNG LIU | Frontiers in Psychiatry | 21 | 18 | |
14 | 2019 | Advanced Paternal Age and Early Onset of Schizophrenia in Sporadic Cases: Not Confounded by Parental Polygenic Risk for Schizophrenia | Wang S.-H.; Hsiao P.-C.; Yeh L.-L.; CHIH-MIN LIU ; CHEN-CHUNG LIU ; TZUNG-JENG HWANG ; MING-HSIEN HSIEH ; YI-LING CHIEN ; YI-TING LIN ; Huang Y.-T.; Chen C.-Y.; Chandler S.D.; Faraone S.V.; Neale B.; Glatt S.J.; Tsuang M.T.; HAI-GWO HWU ; WEI J. CHEN | Biological Psychiatry | 16 | 14 | |
15 | 2019 | Trajectories after first-episode psychosis: Complement to ambiguous outcomes of long-term antipsychotic treatment by exploring a few hidden cases | CHEN-CHUNG LIU ; YI-TING LIN ; CHIH-MIN LIU ; MING-HSIEN HSIEH ; YI-LING CHIEN ; TZUNG-JENG HWANG ; HAI-GWO HWU | Early Intervention in Psychiatry | 3 | 3 | |
16 | 2018 | Polygenic risk for schizophrenia and neurocognitive performance in patients with schizophrenia | Wang S.-H.; Hsiao P.-C.; Yeh L.-L.; CHIH-MIN LIU ; CHEN-CHUNG LIU ; TZUNG-JENG HWANG ; MING-HSIEN HSIEH ; YI-LING CHIEN ; YI-TING LIN ; Chandler S.D.; Faraone S.V.; Laird N.; Neale B.; McCarroll S.A.; Glatt S.J.; Tsuang M.T.; HAI-GWO HWU ; WEI J. CHEN | Genes, Brain and Behavior | 29 | 26 | |
17 | 2016 | Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue | Lai C.-Y.; Lee S.-Y.; Scarr E.; Yu Y.-H.; YI-TING LIN ; CHIH-MIN LIU ; TZUNG-JENG HWANG ; MING-HSIEN HSIEH ; CHEN-CHUNG LIU ; YI-LING CHIEN ; Udawela M.; Gibbons A.S.; Everall I.P.; HAI-GWO HWU ; Dean B.; WEI J. CHEN | Translational psychiatry | 57 | 53 | |
18 | 2015 | Neurocognitive functioning of subjects with putative pre-psychotic states and early psychosis | CHEN-CHUNG LIU ; Hua M.-S.; TZUNG-JENG HWANG ; Chiu C.-Y.; CHIH-MIN LIU ; MING-HSIEN HSIEH ; YI-LING CHIEN ; YI-TING LIN ; HAI-GWO HWU | Schizophrenia Research | 21 | 19 | |
19 | 2014 | A recently-discovered NMDA receptor gene, GRIN3B, is associated with duration mismatch negativity | YI-TING LIN ; MING-HSIEN HSIEH ; CHEN-CHUNG LIU ; TZUNG-JENG HWANG ; YI-LING CHIEN ; HAI-GWO HWU ; CHIH-MIN LIU | Psychiatry Research | 13 | 13 | |
20 | 2013 | A Diagnostic Model Incorporating P50 Sensory Gating and Neuropsychological Tests for Schizophrenia | Shan, J.-C.; CHIH-MIN LIU ; MING-JANG CHIU ; CHEN-CHUNG LIU ; YI-LING CHIEN ; TZUNG-JENG HWANG ; YI-TING LIN ; MING-HSIEN HSIEH ; Jaw, F.-S.; FU-SHAN JAW | PLoS ONE | 9 | 8 | |
21 | 2012 | Differentiation of schizophrenia patients from healthy subjects by mismatch negativity and neuropsychological tests | YI-TING LIN ; CHIH-MIN LIU ; MING-JANG CHIU ; CHEN-CHUNG LIU ; YI-LING CHIEN ; TZUNG-JENG HWANG ; Jaw, F.-S.; Shan, J.-C.; MING-HSIEN HSIEH ; FU-SHAN JAW | PLoS ONE | 33 | 23 |